Literature DB >> 6766124

Chronic experimental glaucoma in primates. I. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells.

H A Quigley, E M Addicks.   

Abstract

Chronic elevations of intraocular pressure (IOP) were produced in rabbit and monkey eyes by anterior chamber injection of autologous fixed red blood cells. The method confirms the possibility of secondary glaucoma due to trabecular obstruction by ghost cells in eyes with intraocular hemorrhage. In primates, decreased aqueous outflow may result from direct obstruction by free cells and macrophages as well as swelling of trabecular endothelium following phagocytosis of cellular debris. IOP elevations for from 2 days to greater than 1 month were produced in order to study the effects of elevated IOP on ocular tissues. The model has the advantages of producing IOP elevation easily and without associated intraocular inflammation. The extensive filling of the anterior chamber necessary to produce IOP rises in healthy animal eyes leads to the disadvantage of poor visibility of the optic disk. In rabbit eyes, chronic IOP elevation leads to corneal enlargement and ectasia, making IOP measurements difficult.

Entities:  

Mesh:

Year:  1980        PMID: 6766124

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  24 in total

1.  Deformation of the early glaucomatous monkey optic nerve head connective tissue after acute IOP elevation in 3-D histomorphometric reconstructions.

Authors:  Hongli Yang; Hilary Thompson; Michael D Roberts; Ian A Sigal; J Crawford Downs; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

Review 2.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

3.  Quality of bevacizumab compounded for intravitreal administration.

Authors:  J M Palmer; W M Amoaku; F Kamali
Journal:  Eye (Lond)       Date:  2013-06-21       Impact factor: 3.775

4.  Physiologic intereye differences in monkey optic nerve head architecture and their relation to changes in early experimental glaucoma.

Authors:  Hongli Yang; J Crawford Downs; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-04       Impact factor: 4.799

Review 5.  Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure.

Authors:  John C Morrison; William O Cepurna; Elaine C Johnson
Journal:  Exp Eye Res       Date:  2015-05-21       Impact factor: 3.467

6.  The non-human primate experimental glaucoma model.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-06-09       Impact factor: 3.467

7.  Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.

Authors:  P Liu; M Zhang; M Shoeb; D Hogan; Luosheng Tang; M F Syed; C Z Wang; G A Campbell; N H Ansari
Journal:  Free Radic Biol Med       Date:  2014-02-06       Impact factor: 7.376

8.  Monkey trabecular meshwork cells in culture: growth, morphologic, and biochemical characteristics.

Authors:  B Y Yue; A Kurosawa; J L Elvart; V M Elner; M O Tso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

9.  Functional and structural changes in a canine model of hereditary primary angle-closure glaucoma.

Authors:  Sinisa D Grozdanic; Helga Kecova; Matthew M Harper; Wijitha Nilaweera; Markus H Kuehn; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

10.  Development of a Smart Pump for Monitoring and Controlling Intraocular Pressure.

Authors:  Simon A Bello; Sharad Malavade; Christopher L Passaglia
Journal:  Ann Biomed Eng       Date:  2016-09-27       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.